Improved imaging and the clinician: The the role of positron emission tomography in the management of colorectal cancer

被引：5
作者：
Hecht, JR [1 ]
机构：
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
来源：
MOLECULAR IMAGING AND BIOLOGY | 2004年 / 6卷 / 04期
关键词：
colon; colorectal; PET; staging; diagnosis;
D O I：
10.1016/j.mibio.2004.04.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Colorectal cancer is the second most common cause of cancer death in the United States and Western Europe. Positron emission tomography (PET) has been shown to be a valuable tool for the evaluation of malignancies of the breast, lung, and gastrointestinal tract. Potential areas of utility in patients with colorectal cancer include early detection, improved staging at the time of initial diagnosis, the detection and staging of recurrent disease, and early determination of treatment response. Despite continued advancement in the technical aspects of PET, the true measure of its worth is how well it assists the clinician in the care of the patient. To best use the information provided by PET, the nuclear medicine physician and oncologist must both understand the treatment choices available for patients at various stages in the disease. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码：208 / 213
页数：6
相关论文
共 64 条
[41]   Therapeutic potential of ABX-EGF: A fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment [J].
Lynch, DH ;
Yang, XD .
SEMINARS IN ONCOLOGY, 2002, 29 (01) :47-50
[42]   REDUCING MORTALITY FROM COLORECTAL-CANCER BY SCREENING FOR FECAL OCCULT BLOOD [J].
MANDEL, JS ;
BOND, JH ;
CHURCH, TR ;
SNOVER, DC ;
BRADLEY, GM ;
SCHUMAN, LM ;
EDERER, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) :1365-1371
[43]   Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis [J].
Martin, R ;
Paty, P ;
Fong, YM ;
Grace, A ;
Cohen, A ;
DeMatteo, R ;
Jarnagin, W ;
Blumgart, L .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (02) :233-241
[44]  
Meta J, 2001, J NUCL MED, V42, P586
[45]  
MILLER BA, 1993, SEER CANC STAT REV 1
[46]   LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
GOODMAN, PJ ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358
[47]   AN EVALUATION OF THE CARCINOEMBRYONIC ANTIGEN (CEA) TEST FOR MONITORING PATIENTS WITH RESECTED COLON-CANCER [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
TANGEN, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :943-947
[48]  
Mukai M, 2000, ONCOL REP, V7, P85
[49]   PREVENTION OF COLORECTAL-CANCER BY FLEXIBLE ENDOSCOPY AND POLYPECTOMY - A CASE-CONTROL STUDY OF 32702 VETERANS [J].
MULLER, AD ;
SONNENBERG, A .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (12) :904-+
[50]  
Nakamura S, 1999, J Hepatobiliary Pancreat Surg, V6, P16, DOI 10.1007/s005340050079
1234567